As background, this lawsuit was filed on June 22, 2020. (Doc. No. 1.) The original Pretrial Scheduling Order issued on September 23, 2020. (Doc. No. 24.) An Amended Pretrial Scheduling Order issued on November 25, 2020, after FBN and Dr. Sleper were added to the case, resetting the deadlines. (Doc. No. 59 at 3 (stating “Defendants Sleper and Farmer's Business Network must make their initial disclosures under Fed. R. Civ. P. 25(a)(1) on or before December 9, 2020. Plaintiff Syngenta and Defendant Warner may supplement their initial disclosures by December 9, 2020”) (emphasis in original).) All parties were required provide a copy of their initial disclosure documents by January 6, 2021, to the extent they were in that party's possession and control. (Id.) The Amended Pretrial Scheduling Order set the deadline of June 30, 2021, for all written fact discovery to be completed.
[2] (Id. at 5.) The Order also expressly reminded the parties of their continual obligation to supplement pursuant to Federal Rule of Civil Procedure 26(e): “All parties remain obligated to make supplemental disclosures in a timely manner as required by Rule 26(e).” (Id. at 3.)
*2 Federal Rule of Civil Procedure 26(e) provides:
A party who has made a disclosure under Rule 26(a)—or who has responded to an interrogatory, request for production, or request for admission—must supplement or correct its disclosure or response:
(A) in a timely manner if the party learns that in some material respect the disclosure or response is incomplete or incorrect, and if the additional or corrective information has not otherwise been made known to the other parties during the discovery process or in writing[.]
Fed. R. Civ. P. 26(e)(1) (emphasis added).
Syngenta, without consulting with the other parties, and without seeking an amendment of the Court's pretrial scheduling order, served supplemental responses to various interrogatory answers on October 8, 2021 and October 29, 2021—approximately three months after the written fact discovery deadline closed on June 30, 2021, and after the close of fact discovery.
[3] Defendants objected, and following a meet and confer, filed their motion to exclude.
At the hearing, Syngenta explained that it was not clear on how this Court might interpret Rule 26(e), so in an abundance of caution, Syngenta updated their interrogatory answers with information that was produced in discovery after Syngenta's last interrogatory answers were served. Syngenta's updates included references to deposition testimony, deposition exhibits, and other documents by Bates number. Syngenta concedes that all of the supplemental information added to its answers had been previously made known to Defendants during discovery.
Because all of the supplemental information added to Syngenta's answers had “been made known to the other parties during the discovery process,” Syngenta's supplemental answers do not qualify as Rule 26(e) material and Rule 26(e) is not a vehicle for allowing Syngenta's supplementation after the June 30, 2021 written discovery deadline expired. Nor did Syngenta attempt to amend the Pretrial Scheduling Order to extend the written discovery deadline to supplement written discovery. Accordingly, Syngenta's supplementation was not allowed and it must withdraw its supplemental answers to the interrogatories at issue (or the supplemental answers are otherwise stricken).
[4] The Court, however, does not “exclude” such information from evidence, as was requested by Defendants; instead, the Court will have the supplementations provided in the interrogatory answers effectively erased. Syngenta must file a letter no later than January 17, 2022, attaching each of the supplemental sets of interrogatories that were subject to Defendants’ motion to exclude, stating that Syngenta formally withdraws each of the supplemental responses at issue.
And finally, also for the purpose of providing clarification to avoid future disputes, the Court emphasizes that this Order in no way permits Syngenta to supplement the identification of Syngenta's alleged trade secrets. Such identification was required by disclosure and pursuant to the Court's Pretrial Scheduling Orders. (See, e.g., Doc. No. 59.) This Court's November 25, 2020 Amended Pretrial Scheduling Order set a date certain for Syngenta to identify completely its alleged trade secrets no later than December 21, 2020. (Doc. No. 59 at 4.) The Pretrial Scheduling Order noted that the identification of the asserted trade secret “may be amended as the case proceeds”; however, the Court required the parties to jointly propose a procedure for any amendment as discovery progressed and the joint proposal needed to be filed by January 6, 2021. (Id.) On January 6, 2021, the parties informed the Court that they were unable to agree on a joint proposal for amendment and they proposed separate amendments. (Doc. No. 76.) On January 19, 2021, after consideration of the parties’ proposals, the Court issued the following addendum to the Amended Pretrial Scheduling Order:
Plaintiff may amend its identification of trade secrets as provided by the First Amended Pretrial Scheduling Order only by Stipulation or by leave of Court for good cause shown. By way of one example, absent undue prejudice to the non-moving party, good cause could include Plaintiff's discovery of new information that was only made available to Plaintiff through discovery methods. This example of good cause assumes Plaintiff was diligent in pursuing such discovery, timely reviewed it, and promptly sought any amendment.
If Plaintiff seeks leave to amend its identification of trade secrets, it must meet and confer with Defendant before filing a motion. If, after the meet and confer, the parties do not agree and the dispute is not resolved, Plaintiff may file its motion pursuant to Local Rule 7.1.
(Doc. No. 93 at 1.) Then, in a March 9, 2021 Order granting in part and denying in part FBN's Motion Regarding Plaintiff Syngenta Seeds, LLC's Violation of the Court's Amended Pretrial Scheduling Order (Doc. No. 108), the Court addressed Syngenta's identification of its trade secrets once more, stating the following:
The trade secret disclosure requires Syngenta to describe the information reasonably believed to have been misappropriated based upon the information available at this time. Syngenta claims that it could not produce the data further describing the trade secrets identified in its trade secret disclosures until the Protective Order was amended. The Court has now approved the Second Amended Protective Order. Accordingly, Syngenta is ordered to supplement its trade secret disclosure to produce and identify by Bates Number any data or information supporting its trade secret disclosure. Further, Syngenta must clearly associate each document with the corresponding paragraph in the trade secret disclosure. If any document has elements that are not at issue, Syngenta's amended trade secret disclosure must clearly identify what parts of a document are at issue. Syngenta must produce its Amended Trade Secret Disclosure and all corresponding documents within 21 days after the Second Amended Protective Order is filed.
*4 In addition, Syngenta must also supplement its initial disclosures and produce “a copy—or a description by category and location—of all documents, electronically stored information, and tangible things that the disclosing party has in its possession, custody, or control and may use to support its claims or defenses, unless the use would be solely for impeachment” consistent with Fed. R. Civ. P. 26(a)(1)(A), within 21 days after the Second Amended Protective Order is filed. If Syngenta intends to use any of their initial disclosure documents to provide more detail to support its trade secret disclosure, it must identify those documents by Bates Number and the Amended Trade Secret Disclosure must clearly identify what part of any document is at issue. If documents are described by a category, any documents in Syngenta's possession, custody, and control must be produced within 21 days after the Second Amended Protective Order is filed.
Except for this new ruling herein, the Court's Amended Pretrial Scheduling Order (Doc. No. 59) and Addendum to the First Amended Pretrial Scheduling Order (Doc. No. 93), otherwise remain in full force and effect.
(Doc. No. 164 at 4 (emphasis in original).) Thus, Syngenta is—and was—only permitted to amend its identification of alleged trade secrets pursuant to the Pretrial Scheduling Order, the Addendum, and in connection with the Court's March 19, 2021 Order as stated above. The Court's Order today does not extend or resurrect the deadline for Syngenta's identification of alleged trade secrets.